Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein

BACKGROUND: Human papilloma virus (HPV) is implicated in >99% of cervical cancers and ∼40% of head and neck squamous cell carcinoma (HNSCC). We previously targeted E6 oncogene with (188)Rhenium-labelled monoclonal antibody (mAb) C1P5 to HPV16 E6 in cervical cancer and HNSCC. Intranuclear E6 can b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Harris, M, Wang, X G, Jiang, Z, Phaeton, R, Koba, W, Goldberg, G L, Casadevall, A, Dadachova, E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590678/
https://ncbi.nlm.nih.gov/pubmed/23385729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.43
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados